Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X0002 Spray for Pain Relief in Knee Osteoarthritis
NCT03081806Phase 3Completed
- Sponsor
- Techfields Pharma
- Start
- Sep 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofenamine hydrochloride in osteoarthritis (OA), sponsored by Techfields Pharma. Started Sep 2021; status: completed.
02
Drugs
ibuprofenamine hydrochloride
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03081806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03081806.